Golden Ally Lifetech Group, Inc.
AQPW
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.43M | 1.01M | 1.42M | 1.58M | 1.96M |
| Depreciation & Amortization | -- | -- | -- | 5.80K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.43M | 1.09M | 1.42M | 1.59M | 1.96M |
| Operating Income | -2.43M | -1.09M | -1.42M | -1.59M | -1.96M |
| Income Before Tax | -2.43M | -1.09M | -1.42M | -1.59M | -1.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.43M | -1.09M | -1.42M | -1.59M | -1.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.43M | -1.09M | -1.42M | -1.59M | -1.96M |
| EBIT | -2.43M | -1.09M | -1.42M | -1.59M | -1.96M |
| EBITDA | -- | -- | -- | -1.58M | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 7.41B | 17.38B | 8.48B | 7.94B | 8.50B |
| Average Diluted Shares Outstanding | 7.41B | 17.38B | 8.48B | 7.94B | 8.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |